Physician profile
Laura Arnold
NPI 1689990251
$10,335.12
in general payments reported to CMS, 2019-2025
32 companies · $494 in 2025
The $494 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $172 · 2021: $359 · 2022: $365 · 2023: $8,226 · 2024: $332 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $1,411 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $1,411.37 |
| Travel and Lodging | $140.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,640.47 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $393.17 | 2019-2023 | Lo Loestrin Fe |
| Biogen, INC. | $308.69 | 2024-2025 | Zurzuvae, Vumerity |
| Exeltis, USA INC. | $201.29 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $177.75 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $163.74 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $161.17 | 2019-2025 | Aptima, Novasure |
| Evofem Biosciences, INC. | $127.01 | 2021-2025 | Solosec, Phexx, Phexxi |
| Aspira Women'S Health INC | $118.88 | 2021-2022 | |
| Agile Therapeutics, INC. | $117.68 | 2021-2024 | Twirla |
| Shield Therapeutics INC | $113.33 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $94.62 | 2021-2025 | |
| Minerva Surgical, INC | $92.46 | 2023 | |
| Pfizer INC. | $75.03 | 2023-2025 | |
| Therapeuticsmd, INC. | $64.18 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $49.50 | 2023 | Injectafer |
| Lupin INC. | $48.98 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $44.48 | 2023-2024 | Myfembree |
| Medtronic, INC. | $42.95 | 2023-2024 | V-Loc 180, Ligasure |
| Merck Sharp & Dohme LLC | $42.92 | 2020-2021 | |
| Glaxosmithkline, LLC. | $33.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.09 | 2019-2020 | |
| Innovation Technologies INC | $29.00 | 2023 | Irrisept |
| Myovant Sciences INC. | $24.29 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.76 | 2023 | Iovera, Zilretta, Exparel |
| Allergan, INC. | $22.44 | 2019-2020 | |
| Ethicon US, LLC | $20.85 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $18.14 | 2023 | Vivjoa |
| Avion Pharmaceuticals | $14.98 | 2019 | |
| Exact Sciences Corporation | $14.52 | 2025 | Cologuard Collection Kit |
| Novum Pharma, LLC | $14.25 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.